Clincosm LogoSign in Get a demo

AML

Showing 76 - 100 of 149
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Aml, AML, Adult Trial (Nivolumab, Azacitidine)

Withdrawn
  • Aml
  • AML, Adult
  • (no location specified)
Oct 9, 2020

Acute Mieloblastic Leukemia in Patients Older Than 60 Years

Completed
  • AML
  • Registry of AML patients > 60 years
  • Alicante, Spain
  • +19 more
May 25, 2020

Acute Myeloid Leukemia, Leukemia, Myelodysplastic Syndrome Trial in Georgia, United States (AC220)

Completed
Has Results
  • Acute Myeloid Leukemia
  • +4 more
  • Birmingham, Alabama
  • +4 more
Apr 23, 2020

Italian Non-Interventional Study of FLT3 Mutated AML Patients

Unknown status
  • AML
  • +2 more
  • Clinical and Molecular data collection
  • Ancona, AN, Italy
  • +32 more
Apr 20, 2020

FLT3-ITD Mutation, AML Trial in Hong Kong (Sorafenib 200mg)

Completed
  • FLT3-ITD Mutation
  • AML
  • Sorafenib 200mg
  • Hong Kong, Hong Kong
    The University of Hong Kong
Mar 26, 2020

AML, FLT3-ITD Mutation Trial in Hong Kong (Sorafenib, Omacetaxine Mepesuccinate Injection)

Completed
  • AML
  • FLT3-ITD Mutation
  • Hong Kong, Hong Kong
    The University of Hong Kong
Mar 26, 2020

AML Trial in Tianjin (Cytarabine, all-trans retinoic acid, Arsenic Trioxide)

Recruiting
  • AML
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Mar 19, 2020

Leukemia, AML, MDS Trial in Houston (Azacitidine)

Completed
Has Results
  • Leukemia
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 6, 2020

Hodgkin Lymphoma, Lymphocytic Leukemia, Mixed Cell Leukemia Trial run by the NCI (Stem cell transplantation)

Completed
  • Hodgkin Lymphoma
  • +8 more
  • Stem cell transplantation
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 13, 2019

AML, MDS Trial in Madison (FLT-PET scans)

Terminated
  • AML
  • MDS
  • FLT-PET scans
  • Madison, Wisconsin
    University of Wisconsin
Dec 12, 2019

MDS, Acute Myeloid Leukemia, AML Trial in Saint Louis (CX-01, Azacitidine, Bone marrow biopsy)

Completed
  • Myelodysplastic Syndromes
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Dec 4, 2019

AML, ALL, Undifferentiated Leukemia Trial in Boston (Abatacept)

Completed
Has Results
  • AML
  • +11 more
  • Boston, Massachusetts
    Boston Children's Hospital
Oct 31, 2019

MDS, AML, Solid Tumors Trial in United States (azacitidine)

Completed
Has Results
  • MDS
  • +5 more
  • Berkeley, California
  • +10 more
Nov 6, 2019

Ascorbic Acid Levels in MDS, AML, and CMML Patients

Completed
  • Myelodysplastic Syndromes
  • +5 more
  • Peripheral blood collection
  • Grand Rapids, Michigan
  • +1 more
Sep 30, 2019

Leukemia, Myeloid, Chronic, Lymphomas, Multiple Myeloma Trial in Minneapolis (Donor Lymphocyte Infusion, Induction Chemotherapy)

Terminated
Has Results
  • Leukemia, Myeloid, Chronic
  • +6 more
  • Donor Lymphocyte Infusion
  • Induction Chemotherapy
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Jul 10, 2019

Myeloid Leukemias, AML, Leukemia Trial in Philadelphia (Rapamycin, Mitoxantrone, Etoposide, Cytarabine, Rapamycin + MEC)

Completed
  • Myeloid Leukemias
  • +3 more
  • Rapamycin, Mitoxantrone, Etoposide, Cytarabine
  • Rapamycin + MEC
  • Philadelphia, Pennsylvania
    University of Pennsylvania Abramson Cancer Center
Jul 10, 2019

AML Trial in Beijing (Decitabine 20 mg/m²/day for 5 days)

Completed
  • AML
  • Decitabine 20 mg/m²/day for 5 days
  • Beijing, Beijing, China
    Navy General Hospital
Jun 6, 2019

Pre-emptive Immunomodulation After Allogeneic Stem Cell

Unknown status
  • AML
  • immunomodulation
  • Caen, France
    University Hospital
Apr 18, 2019

AML Trial in La Jolla (AMLCTL)

Terminated
Has Results
  • AML
  • AMLCTL
  • La Jolla, California
    UCSD
Apr 2, 2019

AML Trial in Tianjin (Cytarabine, Chidamide)

Recruiting
  • AML
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Mar 21, 2019

AML Trial in Tianjin (Daunomycin and Cytarabine (DA Regimen), Daunomycin and Cytarabine (Intermediate Dose of DA Regimen))

Unknown status
  • AML
  • Daunomycin and Cytarabine (DA Regimen)
  • Daunomycin and Cytarabine (Intermediate Dose of DA Regimen)
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Mar 21, 2019

AML Trial in Tianjin (Decitabine)

Suspended
  • AML
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Mar 21, 2019

AML, MDS, CMML Trial in United States (E6201)

Terminated
Has Results
  • AML
  • +2 more
  • Denver, Colorado
  • +3 more
Mar 7, 2019

AML, Relapse Trial in Berne (Epacadostat, Cladribine, Cytarabine)

Withdrawn
  • AML
  • Relapse
  • Berne, Switzerland
    Departement of Medical Oncology, University Hospital Berne
Sep 7, 2018

AML Trial in Berne (Epacadostat, Idarubicin, Cytarabine)

Withdrawn
  • AML
  • Berne, Switzerland
    Departement of Medical Oncology, University Hospital Berne
Sep 7, 2018